Cited by 407Diabetes Management and EducationDiabetes Management and ResearchMedication Adherence and Compliance

The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.

Correlates of Insulin Injection Omission

Open access

Peyrot, Mark, Rubin, Richard R., Kruger, Davida F., Travis, Luther B.·2010·Diabetes Care

Open this paper in CoChat — free account Open PDF

Abstract

OBJECTIVE: The purpose of this study was to assess factors associated with patient frequency of intentionally skipping insulin injections. RESEARCH DESIGN AND METHODS: Data were obtained through an Internet survey of 502 U.S. adults self-identified as taking insulin by injection to treat type 1 or type 2 diabetes. Multiple regression analysis assessed independent associations of various demographic, disease, and injection-specific factors with insulin omission. RESULTS: Intentional insulin omission was reported by more than half of respondents; regular omission was reported by 20%. Significant independent risk factors for insulin omission were younger age, lower income and higher education, type 2 diabetes, not following a healthy diet, taking more daily injections, interference of injections with daily activities, and injection pain and embarrassment. Risk factors differed between type 1 and type 2 diabetic patients, with diet nonadherence more prominent in type 1 diabetes and age, education, income, pain, and embarrassment more prominent in type 2 diabetes. CONCLUSIONS: Whereas most patients did not report regular intentional omission of insulin injections, a substantial number did. Our findings suggest that it is important to identify patients who intentionally omit insulin and be aware of the potential risk factors identified here. For patients who report injection-related problems (interference with daily activities, injection pain, and embarrassment), providers should consider recommending strategies and tools for addressing these problems to increase adherence to prescribed insulin regimens. This could improve clinical outcomes.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.2337/dc09-1348

Cites

24 of 24 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Medical Management of Hyperglycemia in Type 2 Diabetes: A Consensus Algorithm for the Initiation and Adjustment of Therapy
Nathan, D. M., Buse, J. B., Davidson, M. B., Ferrannini, E., Holman, R. R., Sherwin, R., & Zinman, B. (2009) · Diabetes Care · doi:10.2337/dc08-9025 · Cited by 3,834
Relationship of Depression and Diabetes Self-Care, Medication Adherence, and Preventive Care
Lin, E. H. B., Katon, W., Von Korff, M., Rutter, C., Simon, G. E., Oliver, M., Ciechanowski, P., Ludman, E. J., Bush, T., & Young, B. (2004) · Diabetes Care · doi:10.2337/diacare.27.9.2154 · Cited by 1,146
Depression and Diabetes Treatment Nonadherence: A Meta-Analysis
Gonzalez, J. S., Peyrot, M., McCarl, L. A., Collins, E. M., Serpa, L., Mimiaga, M. J., & Safren, S. A. (2008) · Diabetes Care · doi:10.2337/dc08-1341 · Cited by 1,060
Self-citation
Depression, Self-Care, and Medication Adherence in Type 2 Diabetes
Gonzalez, J. S., Safren, S. A., Cagliero, E., Wexler, D. J., Delahanty, L., Wittenberg, E., Blais, M. A., Meigs, J. B., & Grant, R. W. (2007) · Diabetes Care · doi:10.2337/dc07-0158 · Cited by 579
Adherence to insulin treatment, glycaemic control, and ketoacidosis in insulin-dependent diabetes mellitus
Morris, A. D., Boyle, D. I., McMahon, A. D., Greene, S. A., MacDonald, T. M., & Newton, R. W. (1997) · The Lancet · doi:10.1016/s0140-6736(97)06234-x · Cited by 507
Impact of Dosage Frequency on Patient Compliance
Paes, A. H. P., Bakker, A., & Soe-Agnie, C. J. (1997) · Diabetes Care · doi:10.2337/diacare.20.10.1512 · Cited by 411
Adherence to pharmacologic therapy in patients with type 2 diabetes mellitus
Rubin, R. R. (2005) · The American Journal of Medicine · doi:10.1016/j.amjmed.2005.04.012 · Cited by 403
Self-citation
Medication adherence and the associated health-economic impact among patients with type 2 diabetes mellitus converting to insulin pen therapy: An analysis of third-party managed care claims data
Lee, W. C., Balu, S., Cobden, D., Joshi, A. V., & Pashos, C. L. (2006) · Clinical Therapeutics · doi:10.1016/j.clinthera.2006.10.004 · Cited by 262
Behavioral and Psychosocial Interventions in Diabetes
Peyrot, M., & Rubin, R. R. (2007) · Diabetes Care · doi:10.2337/dc07-1222 · Cited by 247
Self-citation
The resources that matter: fundamental social causes of health disparities and the challenge of intelligence.
Link, B. G., Phelan, J. C., Miech, R., & Westin, E. L. (2008) · Journal of Health and Social Behavior · doi:10.1177/002214650804900106 · Cited by 234

Flagged first, then by citations

Show all 24 references

Research works printed but not linked: 1

2008, Centers for Disease Control and Prevention (CDC) National Center for Health Statistics, Division of Health Interview Statistics, data from the National Health Interview Survey

Sorted by citations

Items 201–300 of 405

Evaluation of a new durable insulin pen with memory function among people with diabetes and healthcare professionals
Guo, X., Sommavilla, B., Vanterpool, G. E., Qvist, M., Bethien, M., & Lilleøre, S. K. (2012) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2012.671808 · Cited by 15
Advances in Insulin Therapy: A Review of New Insulin Glargine 300 Units/mL in the Management of Diabetes
White, J. R. (2016) · Clinical Diabetes · doi:10.2337/diaclin.34.2.86 · Cited by 15
A look into the future: improving diabetes care by 2015
Brunton, S., Gough, S. C. L., Hicks, D., Weng, J., Moghissi, E. S., Peyrot, M. F., Schneider, D., Schumm-Draeger, P. M., Tobin, C. T., & Barnett, A. H. (2011) · Current Medical Research and Opinion · doi:10.1185/03007995.2011.603300 · Cited by 16
Self-citation
Insulin non-persistence among people with type 2 diabetes: how to get your patients to stay on insulin therapy
Garnero, T. L., Davis, N. J., Perez-Nieves, M., Hadjiyianni, I., Cao, D., Ivanova, J. I., & Peyrot, M. (2018) · Postgraduate Medicine · doi:10.1080/00325481.2018.1457396 · Cited by 14
Self-citation
Association of HbA1c to BOLUS Scores Among Youths with Type 1 Diabetes
Clements, M. A., DeLurgio, S. A., Williams, D. D., Habib, S., Halpin, K. L., & Patton, S. R. (2016) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2015.0352 · Cited by 14
The role of the new basal insulin analogs in addressing unmet clinical needs in people with type 1 and type 2 diabetes
Lajara, R., Cengiz, E., & Tanenberg, R. J. (2017) · Current Medical Research and Opinion · doi:10.1080/03007995.2017.1298522 · Cited by 14
Carbohydrate knowledge, lifestyle and insulin: an observational study of their association with glycaemic control in adults with type 1 diabetes
Smythe, K., Saw, M., Mak, M., & Wong, V. (2018) · Journal of Human Nutrition and Dietetics · doi:10.1111/jhn.12561 · Cited by 14
Treatment satisfaction and quality-of-life between type 2 diabetes patients initiating long- vs. intermediate-acting basal insulin therapy in combination with oral hypoglycemic agents – a randomized, prospective, crossover, open clinical trial
Hermanns, N., Kulzer, B., Kohlmann, T., Jacob, S., Landgraf, W., Theobald, K., & Haak, T. (2015) · Health and Quality of Life Outcomes · doi:10.1186/s12955-015-0279-4 · Cited by 14
Efficacy and safety of a fixed combination of insulin degludec/insulin aspart in children and adolescents with type 1 diabetes: A randomized trial
Battelino, T., Deeb, L. C., Ekelund, M., Kinduryte, O., KLINGENSMITH, G. J., Kočova, M., Коваренко, М. А., & Shehadeh, N. (2018) · Pediatric Diabetes · doi:10.1111/pedi.12724 · Cited by 14
Clinical and economic considerations based on persistency with a novel insulin delivery device versus conventional insulin delivery in patients with type 2 diabetes: A retrospective analysis
Everitt, B., Harrison, H. C., NIKKEL, C. C., Laswell, E. M., & Chen, A. M. H. (2018) · Research in Social and Administrative Pharmacy · doi:10.1016/j.sapharm.2018.09.016 · Cited by 14
Factors Associated with Insulin Nonadherence in Type 1 Diabetes Mellitus Patients in Mexico
Almeda‐Valdés, P., Palacio, J., Zamudio-Coronado, K. W., de la Parra, D. R., Cabrera, J. B., Gomez-Perez, F. J., Aguilar-Salinas, C. A., & Mehta, R. (2019) · Dubai Diabetes and Endocrinology Journal · doi:10.1159/000502903 · Cited by 14
Assessment of Adherence to Insulin Injections among Diabetic Patients on Basal-Bolus Regimen in Primary and Secondary Healthcare Centers in Al-Jouf Region of Saudi Arabia; A Descriptive Analysis
Alsaidan, A. A., Alsaidan, O. A., Mallhi, T. H., Khan, Y. H., Alzarea, A. I., & Alanazi, A. S. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12103474 · Cited by 19
Clinical challenges with excipients in insulin formulations and role of concentrated insulin
Modi, K. D., Gadge, P. V., Jain, P., Pawar, S. R., Shah, R. D., INGOLE, S. A., & Jain, R. (2019) · International Journal of Basic & Clinical Pharmacology · doi:10.18203/2319-2003.ijbcp20191125 · Cited by 13
Surveillance of an Online Social Network to Assess Population-level
Weitzman, E. R., Keleman, S., & Mandl, K. D. (2011) · Online Journal of Public Health Informatics · doi:10.5210/ojphi.v3i3.3797 · Cited by 13
Non‐adherence to basal insulin among patients with type 2 diabetes in a US managed care population: Results from a patient survey
Stephenson, J. J., Raval, A. D., Kern, D. M., & Bae, J. P. (2018) · Diabetes Obesity and Metabolism · doi:10.1111/dom.13446 · Cited by 13
Developing a Simple 3-Day Insulin Delivery Device to Meet the Needs of People With Type 2 Diabetes
Lilly, L. C., Mader, J. K., & WARNER, J. L. (2018) · Journal of Diabetes Science and Technology · doi:10.1177/1932296818807223 · Cited by 13
Efficacy and safety of insulin degludec U100 and insulin glargine U100 in combination with meal-time bolus insulin in hospitalized patients with type 2 diabetes: an open-label, randomized controlled study
Suzuki, J., Yamakawa, T., Oba, M. S., Nagakura, J., Shigematsu, E., Tamura, H., Takahashi, K., Okamoto, Y., Sakamoto, R., Shinoda, M., et al. (2019) · Endocrine Journal · doi:10.1507/endocrj.ej18-0309 · Cited by 13
Effectiveness of premixed insulin to achieve glycaemic control in type 2 diabetes: A retrospective UK cohort study
Jude, E. B., Trescolí, C., Emral, R., Ali, A., LUBWAMA, R. N., PALMER, K. D., Shaunik, A., Nanda, N., Raskin, P., & Peralta, F. G. (2020) · Diabetes Obesity and Metabolism · doi:10.1111/dom.14298 · Cited by 13
Overview of insulin and non-insulin delivery devices in the treatment of diabetes.
Pisano, M. (2014) · PubMed Central · Cited by 13
Clinical Insights Into a New, Disposable Insulin Delivery Device
Knutsen, P. G., Voelker, C. Q., & NIKKEL, C. C. (2015) · Diabetes Spectrum · doi:10.2337/diaspect.28.3.209 · Cited by 13
Assessing Psychological Insulin Resistance in Type 2 Diabetes: a Critical Comparison of Measures
Holmes‐Truscott, E., Pouwer, F., & Speight, J. (2017) · Current Diabetes Reports · doi:10.1007/s11892-017-0873-4 · Cited by 13
The misuse of insulin by males with Type 1 Diabetes Mellitus for weight and/or shape control: a systematic scoping review
Goddard, G., Oxlad, M., & Turnbull, D. A. (2022) · Journal of Diabetes & Metabolic Disorders · doi:10.1007/s40200-022-01151-8 · Cited by 12
Italian Titration Approach Study (ITAS) with insulin glargine 300 U/mL in insulin-naïve type 2 diabetes: Design and population
Bonadonna, R. C., Giaccari, A., Buzzetti, R., Aimaretti, G., Cucinotta, D., Avogaro, A., Perseghin, G., Larosa, M., Bolli, G. B., & Fanelli, C. G. (2019) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2019.01.011 · Cited by 12
Psychometric Analysis Regarding the Barriers to Providing Effective Insulin Treatment in Type 2 Diabetic Patients
Ku, E. J., Lee, D., Jeon, H. J., Park, F., & Oh, T. K. (2020) · Diabetes Therapy · doi:10.1007/s13300-020-00947-2 · Cited by 13
Insulin Restriction, Emotion Dysregulation, and Depressive Symptoms in Late Adolescents with Diabetes
Beam, A. B., Wiebe, D. J., & Berg, C. A. (2021) · Journal of Pediatric Psychology · doi:10.1093/jpepsy/jsab042 · Cited by 14
Applying the theory of planned behavior to investigate type 2 diabetes patients' intention to receive injection therapy
Hsu, S.-H., Tang, K.-P., Lin, C.-H., Chen, P., & Wang, L. (2023) · Frontiers in Public Health · doi:10.3389/fpubh.2023.1066633 · Cited by 17
Desert date seed extract-loaded chitosan nanoparticles ameliorate hyperglycemia and insulin deficiency through the reduction in oxidative stress and inflammation
Farid, A., Ahmed, A., Alaa, O., & Safwat, G. (2024) · Scientific Reports · doi:10.1038/s41598-024-56352-3 · Cited by 12
Novel Simple Insulin Delivery Device Reduces Barriers to Insulin Therapy in Type 2 Diabetes
Hermanns, N., Lilly, L. C., Mader, J. K., Aberer, F., Ribitsch, A., Kojzar, H., WARNER, J. L., & Pieber, T. R. (2015) · Journal of Diabetes Science and Technology · doi:10.1177/1932296815570709 · Cited by 12
The barriers against initiating insulin therapy among patients with diabetes living in Yazd, Iran
Pour, M. S., Sadeghiyeh, T., Hadavi, M., Besharati, M., & Bidaki, R. (2019) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s200867 · Cited by 13
Self-monitoring of blood glucose measurements and glycaemic control in a managed care paediatric type 1 diabetes practice
Davey, B., & Segal, D. G. (2015) · South African Medical Journal · doi:10.7196/samj.7686 · Cited by 12
Machine learning for predicting hepatitis B or C virus infection in diabetic patients
Kim, S., Park, S., & Lee, H. (2023) · Scientific Reports · doi:10.1038/s41598-023-49046-9 · Cited by 16
Pain and Satisfaction among Type 2 Diabetic Patients: Effects of Coughing, ShotBlocker and Vibration during Insulin Injection: A Randomised Controlled Trial
Abdulyemmah, A. D., & Majeed, H. M. (2025) · Nigerian Postgraduate Medical Journal · doi:10.4103/npmj.npmj_55_25 · Cited by 11
Targeted Adherence Intervention to Reach Glycemic Control with Insulin Therapy for patients with Diabetes (TARGIT-Diabetes): rationale and design of a pragmatic randomised clinical trial
Lewey, J., Wei, W., Lauffenburger, J. C., Makanji, S. S., Chant, A., DiGeronimo, J., Nanchanatt, G., Jan, S., & Choudhry, N. K. (2017) · BMJ Open · doi:10.1136/bmjopen-2017-016551 · Cited by 11
Experiences of Adults Using Continuous Subcutaneous Insulin Infusion: A Qualitative Study
MESBAH, N., Taha, N., Rahme, Z. N., Sukkar, F., & Omar, D. (2019) · Medical Principles and Practice · doi:10.1159/000503705 · Cited by 15
Combining GLP-1 Receptor Agonists and Basal Insulin in Older Adults with Type 2 Diabetes: Focus on Lixisenatide and Insulin Glargine
Handelsman, Y., Muskiet, M. H. A., & Meneilly, G. S. (2019) · Advances in Therapy · doi:10.1007/s12325-019-01126-x · Cited by 12
Insulin Adherence in Adolescents with Type 1 Diabetes Mellitus
Dabas, H., Sarin, J., & Madhu, S. (2023) · Indian Journal of Endocrinology and Metabolism · doi:10.4103/ijem.ijem_294_22 · Cited by 12
ShotBlocker versus vibration device: Which technique reduces pain and increases satisfaction in insulin injection among type 2 diabetes: A randomized controlled trial
Abdulyemmah, A. D., & Majeed, H. M. (2025) · Journal of Integrative Nursing · doi:10.4103/jin.jin_29_25 · Cited by 10
Practical limitations of complex insulin therapies in type 2 diabetes: Focus on therapy simplification using fixed‐ratio combinations of basal insulin and a glucagon‐like peptide‐1 receptor agonist
Horváth, L., Novodvorský, P., & Haluzı́k, M. (2025) · Diabetes Obesity and Metabolism · doi:10.1111/dom.16645 · Cited by 9
Efficacy and safety of ultra-long-acting insulin degludec
Wakil, A., & Atkin, S. L. (2012) · Therapeutic Advances in Endocrinology and Metabolism · doi:10.1177/2042018812437181 · Cited by 10
ADHERENCE IN PREGNANCY: A SYSTEMATIC REVIEW OF THE LITERATURE
Oladejo, M., & Bewley, S. (2012) · Fetal and Maternal Medicine Review · doi:10.1017/s0965539512000113 · Cited by 10
Cost-effectiveness of Simple Insulin Infusion Devices Compared to Multiple Daily Injections in Uncontrolled Type 2 Diabetics in the United States Based on a Simulation Model
Wahlqvist, P., WARNER, J. L., & Morlock, R. (2018) · Journal of health economics and outcomes research · doi:10.36469/9789 · Cited by 10
Dose accuracy and durability of a durable insulin pen before and after simulated lifetime use
Kristensen, C. M., & Lilleøre, S. K. (2011) · Current Medical Research and Opinion · doi:10.1185/03007995.2011.609885 · Cited by 10
Expert Opinion on Optimising Type 2 Diabetes Treatment Using Fixed-Ratio Combination of Basal Insulin and GLP-1 RA for Treatment Intensification and Simplification
Haluzı́k, M., Taybani, Z. J., Araszkiewicz, A., Cerghizan, A., Mankovsky, B., Zuhdi, A., & Malecki, M. T. (2024) · Diabetes Therapy · doi:10.1007/s13300-024-01610-w · Cited by 10
Perspectives and Preferences of People with Type 2 Diabetes for the Attributes of Weekly Insulin
Gelsey, F. T., Schapiro, D., Kosa, K., Vass, C., Perez‐Nieves, M., Pierce, A., Poon, J. L., DiBenedetti, D. B., & Mansfield, C. A. (2024) · Diabetes Therapy · doi:10.1007/s13300-024-01652-0 · Cited by 9
How Much Do We Know about the Biopsychosocial Predictors of Glycaemic Control? Age and Clinical Factors Predict Glycaemic Control, but Psychological Factors Do Not
Abdullah, M. F. I. L. B., Sidi, H., Ravindran, A. V., Gosse, P. J., Kaunismaa, E. S., Mainland, R. L., Mustafa, N., Hatta, N. H., Arnawati, P., Zulkifli, A. Y., et al. (2020) · Journal of Diabetes Research · doi:10.1155/2020/2654208 · Cited by 11
User experiences with second-generation 32-gauge × 4 mm vs. thinner comparator pen needles: prospective randomized trial
Gibney, M. A., Fitzpatrick, D., Klonoff, D. C., Whooley, S., Lu, B., Yue, W., & Glezer, S. (2020) · Current Medical Research and Opinion · doi:10.1080/03007995.2020.1803248 · Cited by 9
Resource utilisation and quality of life following initiation of insulin detemir in patients with type 2 diabetes mellitus
Liebl, A., Andersen, H., Svendsen, A. L., Vora, J. P., Yale, J., & the SOLVE Study Group (2013) · International Journal of Clinical Practice · doi:10.1111/ijcp.12133 · Cited by 9
Effect of prandial treatment timing adjustment, based on continuous glucose monitoring, in patients with type 2 diabetes uncontrolled with once‐daily basal insulin: A randomized, phase IV study
Ilany, J., Bhandari, H., Nabriski, D., Toledano, Y., Konvalina, N., & Cohen, O. (2018) · Diabetes Obesity and Metabolism · doi:10.1111/dom.13214 · Cited by 8
Laboratory and Benchtop Performance of a Mealtime Insulin-Delivery System
Dreon, D. M., Hannon, T. M., Cross, B. L., Carter, B. J., Mercer, N. S., Nguyen, J. H., Tran, A., Meléndez, P. A., Morales, N., Nelson, J. E., et al. (2018) · Journal of Diabetes Science and Technology · doi:10.1177/1932296818760633 · Cited by 9
Efficacy, safety and cost-effectiveness comparison between U-100 human regular insulin and rapid acting insulin when delivered by V-Go wearable insulin delivery device in type 2 diabetes
Mora, P. F., SUTTON, D. R., Gore, A., Baliga, B. S., Goldfaden, R. F., NIKKEL, C. C., Sink, J. H., & ADAMS-HUET, B. A. (2020) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2020-001832 · Cited by 9
Abstract 14
Sharma, D., Mathur, S., Sharma, B., & Saran, S. (2014) · Indian Journal of Endocrinology and Metabolism · doi:10.4103/2230-8210.129714 · Cited by 9
Using Oscillation to Improve the Insertion Depth and Consistency of Hollow Microneedles for Transdermal Insulin Delivery with Mechanistic Insights
Smith, F. N. C., Kotowska, A. M., Fiedler, B., Cerny, E., Cheung, K., Rutland, C. S., Chowdhury, F., Segal, J. I., Rawson, F. J., & Marlow, M. (2024) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.4c00942 · Cited by 8
Insulin degludec is a new ultra-long-acting insulin analogue
Dedov, I. I., & Shestakova, M. V. (2014) · Diabetes Mellitus · doi:10.14341/dm2014291-104 · Cited by 8
Assessing Barriers to Insulin Therapy among Omani Diabetic Patients Attending Three Main Diabetes Clinics in Muscat, Oman
Futaisi, A. A., Al-Osali, M. E., Al-Kazrooni, A., Al-Qassabi, S. S., Gharabi, S. A., Panchatcharam, S. M., & Al-Mahrezi, A. M. (2021) · Sultan Qaboos University medical journal · doi:10.18295/squmj.6.2021.086 · Cited by 8
Combination therapy in type 2 diabetes mellitus: adding empagliflozin to basal insulin
Ahmann, A. (2015) · Drugs in Context · doi:10.7573/dic.212288 · Cited by 8
Advances in Insulin Injection Research Influences Patient Adherence
Aronson, R., Bailey, T. S., Hirsch, L. J., & Saltiel-Berzin, R. (2013) · US Endocrinology · doi:10.17925/use.2013.09.02.114 · Cited by 8
Identifying patients with type 2 diabetes in which basal supported oral therapy may not be the optimal treatment strategy
Bramlage, P., Bluhmki, T., Rathmann, W., Kaltheuner, M., Beyersmann, J., & Danne, T. (2016) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2016.03.015 · Cited by 8
Impact of telephonic interviews on persistence and daily adherence to insulin treatment in insulin-naïve type 2 diabetes patients: dropout study
Yavuz, D. G., Bilen, H., Sancak, S., Garip, T., Hekimsoy, Z., Şahin, İ., Yılmaz, M., Aydin, H., Atmaca, A., Sert, M., et al. (2016) · Patient Preference and Adherence · doi:10.2147/ppa.s100626 · Cited by 8
Initiating Titratable Fixed-Ratio Combinations of Basal Insulin Analogs and Glucagon-Like Peptide-1 Receptor Agonists: What You Need to Know
SKOLNIK, N., Hinnen, D., Kiriakov, Y., MAGWIRE, M. L., & White, J. R. (2018) · Clinical Diabetes · doi:10.2337/cd17-0048 · Cited by 8
Skin Blood Perfusion and Cellular Response to Insertion of Insulin Pen Needles With Different Diameters
Præstmark, K. A., Jensen, C. B., Stallknecht, B. M., Madsen, N. B., & Kildegaard, J. (2014) · Journal of Diabetes Science and Technology · doi:10.1177/1932296814531099 · Cited by 8
Using observational data to inform the design of a prospective effectiveness study for a novel insulin delivery device
Grabner, M., Chen, Nguyen, Abbott, A., & Quimbo (2013) · ClinicoEconomics and Outcomes Research · doi:10.2147/ceor.s46896 · Cited by 7
Effect of V-Go Versus Multiple Daily Injections on Glycemic Control, Insulin Use, and Diabetes Medication Costs Among Individuals with Type 2 Diabetes Mellitus
Raval, A. D., Nguyen, M. H., Zhou, S., Grabner, M., Barron, J. O., & Quimbo, R. A. (2019) · Journal of Managed Care & Specialty Pharmacy · doi:10.18553/jmcp.2019.25.10.1111 · Cited by 11
Comparison of insulin degludec (IDeg)/insulin Aspart (IAsp) co‐formulation therapy twice‐daily with free combination of GLP‐1 receptor agonist liraglutide plus insulin degludec in Tochigi: IDEAL Trial
Aso, Y., Takada, Y., Tomotsune, K., Chiba, Y., Matsumura, M., Jojima, T., Sato, M., Fujita, N., Kuroda, H., Murano, S., et al. (2020) · International Journal of Clinical Practice · doi:10.1111/ijcp.13734 · Cited by 7
Dose accuracy of a durable insulin pen with memory function, before and after simulated lifetime use and under stress conditions
Xue, L., & Mikkelsen, K. H. (2013) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2013.761970 · Cited by 7
A novel option for prandial insulin therapy: inhaled insulin
DAILEY, G. E., Ahmad, A., Polsky, S., & Shah, V. N. (2016) · Postgraduate Medicine · doi:10.1080/00325481.2016.1229555 · Cited by 7
The potential effect of ultra-long insulin degludec on glycemic variability
Rodacki, M., Carvalho, R. M., & Zajdenverg, L. (2017) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2017.06.003 · Cited by 7
Feasibility of Using Accelerometer Measurements to Assess Habitual Physical Activity in Rural Heart Failure Patients
Young, L., Hertzog, M. A., & Barnason, S. A. (2017) · Geriatrics · doi:10.3390/geriatrics2030023 · Cited by 7
Persistence with Basal-Bolus Insulin Therapy in Patients with Type 2 Diabetes Mellitus and Effect on Clinical and Economic Outcomes: A Retrospective Claims Database Study
Edelman, S. V., Ermakova, A., Xiong, Y., Sieradzan, R., & Taylor, S. (2019) · Journal of Managed Care & Specialty Pharmacy · doi:10.18553/jmcp.2019.19097 · Cited by 7
The Unmet Medical Needs of Current Injectable Antidiabetic Therapies in China: Patient and Health Care Professional Perspectives
Chen, T., Zhou, L., Wang, K., Ma, X., Wu, H., Liu, X., Tong, J., Cai, B., & Ji, Q. (2020) · Clinical Therapeutics · doi:10.1016/j.clinthera.2020.06.006 · Cited by 7
Socio-cognitive determinants affecting insulin adherence/non-adherence in late adolescents and young adults with type 1 diabetes: a systematic review protocol
AlBurno, H., Mercken, L. A. G., de Vries, H., Mohannadi, D. A., Jongen, S., & Schneider, F. (2022) · Journal of Diabetes & Metabolic Disorders · doi:10.1007/s40200-022-01054-8 · Cited by 6
Disordered eating behaviors among adolescent patients with type I diabetes mellitus
Madbouly, N. M., El-Bakry, A., Mahmoud, A. A., Kamal, A., Ayoub, D. R., & Kamel, R. M. (2018) · Egyptian Journal of Psychiatry · doi:10.4103/ejpsy.ejpsy_41_17 · Cited by 6
Factors associated with non-adherence to insulin in Type 1 and Type 2 diabetes mellitus patients in Western region of Algeria, Tlemcen: a cross-sectional study
Hacene, M. N. B., Zatla, Y. T., Saker, M., Abbou, Z., Youcef, A., Boulenouar, H., Fekir, H., Khaldi, K., Nigassa, N. B., Lounici, A., et al. (2022) · Pan African Medical Journal · doi:10.11604/pamj.2022.41.172.32972 · Cited by 7
Implantable device actuated by manual button clicks for noninvasive self‐drug administration
Kim, C. R., Cho, Y. C., Lee, S. H., Han, J. H., Kim, M. J., Ji, H. B., Kim, S., Min, C. H., Shin, B. H., Lee, C., et al. (2022) · Bioengineering & Translational Medicine · doi:10.1002/btm2.10320 · Cited by 5
Weight Loss Pharmacotherapy
Jordan, G., Young, S., & Alemán, J. O. (2024) · Gastrointestinal Endoscopy Clinics of North America · doi:10.1016/j.giec.2024.06.006 · Cited by 8
Empowering People with Diabetes: Improving Perceptions and Outcomes with Technical Advances in Insulin Pens
Oyer, D. S., Niemeyer, M., & Moses, A. C. (2012) · Postgraduate Medicine · doi:10.3810/pgm.2012.09.2587 · Cited by 6
Basal and Bolus Insulin Dose Changes after Switching Basal Insulin to Insulin Degludec in Patients with Type 1 Diabetes Mellitus: A Pilot Study
Hamamoto, Y., Honjo, S., Fujimoto, K., Tokumoto, S., Ikeda, H., Wada, Y., & Koshiyama, H. (2017) · Clinical Drug Investigation · doi:10.1007/s40261-017-0541-0 · Cited by 6
Rasch and Confirmatory Factor Analyses of the Arabic Version of the Diabetes Self-Management Scale (DSMS): An Intercultural Approach
Kaabi, Y. A., Alshaikh, N. A., Jerah, A. A., Halawi, M., Habibullah, M. M., & Abdelwahab, S. İ. (2022) · Healthcare · doi:10.3390/healthcare11010035 · Cited by 6
Differential Treatment Response to Insulin Intensification Therapy: A Post Hoc Analysis of a Randomized Trial Comparing Premixed and Basal-Bolus Insulin Regimens
Shi, L. X., Li, P. F., & Hou, J. N. (2017) · Diabetes Therapy · doi:10.1007/s13300-017-0286-z · Cited by 7
Replacing or Supplementing Automated Insulin Delivery With Inhaled Insulin: A 90-Day Randomized Controlled Trial
Kaiserman, K. B., Ulloa, J., Pleitez, J., Sylvan, J., Codorniz, K., Lee, S., Jacobson, C., & Blevins, T. (2025) · Journal of Diabetes Science and Technology · doi:10.1177/19322968251388128 · Cited by 5
Insulin therapy DE ‐ intensificAtion with iGlarLixi : A phase 4, open‐label, parallel‐group randomised controlled trial
Novodvorský, P., Thieme, L., Laňková, I., Franková, Š., Veselá, A., Záhumenský, E., Edelsberger, T., Löblová, M., Žižka, O., Vytasil, M., et al. (2025) · Diabetes Obesity and Metabolism · doi:10.1111/dom.70362 · Cited by 5
Disordered eating behaviours and eating disorders in adults with type 1 diabetes (DEBBI): rational and design of an observational longitudinal online study
Priesterroth, L., Grammes, J., Strohm, E. A., & Kubiak, T. (2022) · BMJ Open · doi:10.1136/bmjopen-2022-064863 · Cited by 6
Overcoming Barriers to Injectable Therapies: Development of the ORBIT Intervention Within a Behavioural Change Framework
McGuigan, K., Hill, A., McCay, D., O’Kane, M., & COATES, V. E. (2021) · Frontiers in Clinical Diabetes and Healthcare · doi:10.3389/fcdhc.2021.792634 · Cited by 5
Insulin and Zinc Co-Administration Ameliorate Diabetes Mellitus-Induced Reproductive Dysfunction in Male Rats
Ujah, G. A. (2022) · Nigerian Journal of Physiological Sciences · doi:10.54548/njps.v37i1.7 · Cited by 5
Patient Perceptions of Satisfaction and Quality of Life Regarding Use of a Novel Insulin Delivery Device
Isaacs, D. M., Kruger, D. F., SHOGER, E., & Chawla, H. (2022) · Clinical Diabetes · doi:10.2337/cd22-0034 · Cited by 5
Self-citation
Insulin for people with type 2 diabetes mellitus
Vanderpant, N., Ward, E., Farrell, E., & Theodoraki, A. (2024) · BMJ · doi:10.1136/bmj-2023-078015 · Cited by 6
adesão de pessoas com diabetes mellitus tipo 2 ao tratamento medicamentoso
Correspondente, A. (2014) · Cited by 5
Patient-reported outcomes from a randomized, crossover trial comparing a pen injector with insulin degludec versus a pen injector with insulin glargine U100 in patients with type 2 diabetes
Warren, M., Brod, M. I., Håkan‐Bloch, J., Sparre, T., & CHAYKIN, L. B. (2019) · Current Medical Research and Opinion · doi:10.1080/03007995.2019.1605769 · Cited by 5
Effectiveness of Group Therapy Reality in Reducing Depression, Anxiety and Increased Compliance to Treatment in Patients with Diabetic Type 1
Farshchi, N., Kiani, Q., & Chiti, H. (2018) · Journal of Advances in Medical and Biomedical Research · doi:10.30699/jambs.30.142.7 · Cited by 5
Insulin Degludec, a Long-Acting Once-Daily Basal Analogue for Type 1 and Type 2 Diabetes Mellitus
Berard, L., & Macneill, G. (2014) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2014.02.019 · Cited by 5
Impact of a Pharmacy-Based Glucose Management Program on Glycemic Control in an Inpatient General Medicine Population
Efird, L. E., Golden, S. H., Visram, K., & Shermock, K. M. (2014) · Hospital Practice · doi:10.3810/hp.2014.02.1097 · Cited by 5
Review of Clinical Profile of IDegAsp.
Unnikrishnan, A. G., Singh, A. K., Modi, K. D., Saboo, B., Garcha, S. C., & Rao, P. V. (2015) · PubMed · Cited by 5
From Farm to Pharmacy: Strawberry-Enabled Oral Delivery of Protein DrugsPreprint
Lamson, N. G., Fein, K. C., Gleeson, J. P., Xian, S., Newby, A. N., Chaudhary, N., Melamed, J. R., Cochran, K., Ball, R. L., Suri, K., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.03.11.987461 · Cited by 5
Insulin Pumps for Individuals With Type 2 Diabetes
Brown, S. M., Romeo, G. R., & Toschi, E. (2025) · Diabetes Spectrum · doi:10.2337/dsi25-0005 · Cited by 5
Diabetes hospitalizations and deaths in a cohort of treatment-seeking illicit drug users
Aregbesola, A., Onyeka, I. N., Olubamwo, O., Ronkainen, K., Tiihonen, J., Föhr, J., & Kauhanen, J. (2018) · SAGE Open Medicine · doi:10.1177/2050312118768164 · Cited by 4
Comparison of glucose variability in patients with type 2 diabetes administrated glargine with needle-free jet injector and conventional insulin pen
Sun, Y., Wang, J., Li, H., Sun, X., Su, X., & Ma, J. (2020) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2020.1738381 · Cited by 4
Should we Fear Insulin Therapy in the Treatment of Type 2 Diabetes?
Haslam, D. B. (2014) · The Open Obesity Journal · doi:10.2174/1876823701406010070 · Cited by 4
Intensifying Insulin Therapy in Type 2 Diabetes: Choices & Challenges.
Kumar, A., Kesavadev, J., Sethi, B. K., Jain, S. M., Guruprasad, C. S., & Shah, S. N. (2015) · PubMed · Cited by 4
Diabète de type 2 : observance thérapeutique aux nouveaux antidiabétiques
Halimi, S. (2018) · Médecine des Maladies Métaboliques · doi:10.1016/s1957-2557(18)30132-9 · Cited by 4
Self-care, A1C and stigmatization as predictors of a negative perception of insulin among adults with type 2 diabetes: a hospital-based study in Turkey
Sürücü, H. A., Arslan, H. O., & Çetik, S. (2020) · Journal of Health Research · doi:10.1108/jhr-12-2019-0298 · Cited by 4
Assessment of basal insulin adherence using 2 methodologies among Texas Medicaid enrollees with type 2 diabetes
Zhang, H., Barner, J. C., Moczygemba, L. R., & Rascati, K. L. (2020) · Journal of Managed Care & Specialty Pharmacy · doi:10.18553/jmcp.2020.26.11.1434 · Cited by 5

Authors: Peyrot, M., Rubin, R. R., Kruger, D. F., & Travis, L. B.
Affiliations: Johns Hopkins University (US)
Henry Ford Health (US)
The University of Texas Medical Branch at Galveston (US)
Corresponding author: Peyrot, Mark
ORCID: Peyrot, Mark
Kruger, Davida F.
Venue: Diabetes Care
Publisher: American Diabetes Association
Published: 2010-02-01
Volume: 33
Issue: 2
Pages: 240-245
ISSN: 0149-5992 (ISSN-L)
1935-5548
DOI: 10.2337/dc09-1348
PMC: PMC2809256
OpenAlex: W2103829708
Cited by: 407
References: 24
Citations by year: 2026: 14 · 2025: 15 · 2024: 17 · 2023: 18 · 2022: 18 · 2021: 17 · 2020: 21 · 2019: 30 · 2018: 33 · 2017: 31 · 2016: 38 · 2015: 29 · 2014: 33 · 2013: 37 · 2012: 22
FWCI: 22.33
Type: journal article
Language: en
Open access: hybrid
doi.org
Licence: cc-by-nc-nd
Locations: Diabetes Care (publishedVersion, cc-by-nc-nd)
PubMed Central (publishedVersion, cc-by-nc-nd)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Education
Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
Health Sciences › Medicine › Family Practice › Medication Adherence and Compliance
Keywords: insulin omission, insulin injection, type 1 diabetes, type 2 diabetes, insulin adherence, injection pain, socioeconomic factors, age, insulin regimens
MeSH terms: Adult, Aged, Behavior, Cardiovascular Diseases, Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2, Diabetic Angiopathies, Ethnicity, Female, Health Surveys, Humans, Hypertension, Hypoglycemic Agents, Income, Insulin, Male, Middle Aged, Perception, Regression Analysis, Risk-Taking, Self Care, Racial Groups

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Correlates of Insulin Injection Omission

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks